semaglutide mash pdufa May Reduce Liver Fibrosis in Patients With semaglutide fda approval mash GLP-1

Glp-1 medication works differently than diet alone

The verdict Conditional on most plans Aetna is one of the stronger commercial-coverage stories in the weight-loss GLP-1 space: its pharmacy benefit manager, CVS Caremark, made Wegovy the preferred weight-loss GLP-1 effective July 1, 2025, meaning it is covered with prior authorization on Aetna commercial plans but Aetna's weight-loss-only PA threshold is BMI 35 or higher, stricter than the FDA label (BMI 30 or 27 with a comorbidity)

Consistent dosing and adherence matter too, because irregular exposure breaks the steady metabolic signal the body needs to shift fuel preference

That's accurate as far as it goes

Experts advise combining Ozempic treatment with a hypocaloric diet and regular exercise to maximize the effects